269 related articles for article (PubMed ID: 22984610)
1. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
[TBL] [Abstract][Full Text] [Related]
2. In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.
García-Quiroz J; García-Becerra R; Santos-Martínez N; Barrera D; Ordaz-Rosado D; Avila E; Halhali A; Villanueva O; Ibarra-Sánchez MJ; Esparza-López J; Gamboa-Domínguez A; Camacho J; Larrea F; Díaz L
BMC Cancer; 2014 Oct; 14():745. PubMed ID: 25280486
[TBL] [Abstract][Full Text] [Related]
3. Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells.
García-Becerra R; Díaz L; Camacho J; Barrera D; Ordaz-Rosado D; Morales A; Ortiz CS; Avila E; Bargallo E; Arrecillas M; Halhali A; Larrea F
Exp Cell Res; 2010 Feb; 316(3):433-42. PubMed ID: 19932096
[TBL] [Abstract][Full Text] [Related]
4. ASTEMIZOLE, AN INHIBITOR OF ETHER-À-GO-GO-1 POTASSIUM CHANNEL, INCREASES THE ACTIVITY OF THE TYROSINE KINASE INHIBITOR GEFITINIB IN BREAST CANCER CELLS.
García-Quiroz J; González-González ME; Díaz L; Ordaz-Rosado D; Segovia-Mendoza M; Prado-García H; Larrea F; García-Becerra R
Rev Invest Clin; 2019; 71(3):186-194. PubMed ID: 31184333
[TBL] [Abstract][Full Text] [Related]
5. Calcitriol down-regulates human ether a go-go 1 potassium channel expression in cervical cancer cells.
Avila E; García-Becerra R; Rodríguez-Rasgado JA; Díaz L; Ordaz-Rosado D; Zügel U; Steinmeyer A; Barrera D; Halhali A; Larrea F; Camacho J
Anticancer Res; 2010 Jul; 30(7):2667-72. PubMed ID: 20682996
[TBL] [Abstract][Full Text] [Related]
6. Astemizole inhibits cell proliferation in human prostate tumorigenic cells expressing ether à-go-go-1 potassium channels.
Bernal-Ramos G; Hernández-Gallegos E; Vera E; Chávez-López MG; Zúñiga-García V; Sánchez-Pérez Y; Garrido E; Camacho J
Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):11-13. PubMed ID: 29307346
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative and proapoptotic effects of astemizole on cervical cancer cells.
de Guadalupe Chávez-López M; Hernández-Gallegos E; Vázquez-Sánchez AY; Gariglio P; Camacho J
Int J Gynecol Cancer; 2014 Jun; 24(5):824-8. PubMed ID: 24819656
[TBL] [Abstract][Full Text] [Related]
8. Eag1 Gene and Protein Expression in Human Retinoblastoma Tumors and its Regulation by pRb in HeLa Cells.
Chávez-López MG; Zúñiga-García V; Castro-Magdonel BE; Vera E; Garrido E; Sánchez-Ramos J; Ponce-Castañeda MV; Cabrera-Muñoz ML; Escobar Y; Ortiz CS; Hernández-Gallegos E; Avalos-Fuentes A; Camacho J
Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 31973216
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
[TBL] [Abstract][Full Text] [Related]
10. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
Xu J; Wang Y; Zhang Y; Dang S; He S
Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
[TBL] [Abstract][Full Text] [Related]
11. Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.
Santos-Martínez N; Díaz L; Ordaz-Rosado D; García-Quiroz J; Barrera D; Avila E; Halhali A; Medina-Franco H; Ibarra-Sánchez MJ; Esparza-López J; Camacho J; Larrea F; García-Becerra R
BMC Cancer; 2014 Mar; 14():230. PubMed ID: 24678876
[TBL] [Abstract][Full Text] [Related]
12. Autocrine metabolism of vitamin D in normal and malignant breast tissue.
Townsend K; Banwell CM; Guy M; Colston KW; Mansi JL; Stewart PM; Campbell MJ; Hewison M
Clin Cancer Res; 2005 May; 11(9):3579-86. PubMed ID: 15867263
[TBL] [Abstract][Full Text] [Related]
13. Expression of VDR and CYP24A1 mRNA in human tumors.
Anderson MG; Nakane M; Ruan X; Kroeger PE; Wu-Wong JR
Cancer Chemother Pharmacol; 2006 Jan; 57(2):234-40. PubMed ID: 16180015
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
[TBL] [Abstract][Full Text] [Related]
15. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
16. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
17. Astemizole: an old anti-histamine as a new promising anti-cancer drug.
García-Quiroz J; Camacho J
Anticancer Agents Med Chem; 2011 Mar; 11(3):307-14. PubMed ID: 21443504
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol.
Diesel B; Radermacher J; Bureik M; Bernhardt R; Seifert M; Reichrath J; Fischer U; Meese E
Clin Cancer Res; 2005 Aug; 11(15):5370-80. PubMed ID: 16061850
[TBL] [Abstract][Full Text] [Related]
19. The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
Kim JS; Roberts JM; Bingman WE; Shao L; Wang J; Ittmann MM; Weigel NL
Endocrinology; 2014 Sep; 155(9):3262-73. PubMed ID: 24926821
[TBL] [Abstract][Full Text] [Related]
20. Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC.
de Guadalupe Chávez-López M; Pérez-Carreón JI; Zuñiga-García V; Díaz-Chávez J; Herrera LA; Caro-Sánchez CH; Acuña-Macías I; Gariglio P; Hernández-Gallegos E; Chiliquinga AJ; Camacho J
Tumour Biol; 2015 Aug; 36(8):6149-58. PubMed ID: 25783527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]